Artificial Intelligence Assessment of Chest Radiographs for COVID-19.

Saved in:
Bibliographic Details
Title: Artificial Intelligence Assessment of Chest Radiographs for COVID-19.
Authors: Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: ksasaki1@mdanderson.org., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Nigo M; Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Thompson PA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kontoyiannis DP; Department of Infectious Disease, The University of Texas MD Anderson Cancer Center, Houston, TX., Sato J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Karimaghaei S; McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX., Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Raad II; Department of Infectious Disease, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Carter BW; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Corporate Authors: D3CODE Research Team
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2025 May; Vol. 25 (5), pp. 319-327. Date of Electronic Publication: 2024 Nov 29.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2152-2669
DOI:10.1016/j.clml.2024.11.013